TA
Trevor Allred Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
93.3%
Neutral
6.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Perform
Downgraded
| – | – | 2 | -26% |
0
%
| 5 Mar ‘26 5 days ago |
|
|
|
Outperform
Maintained
| $277 |
31%
upside
| 5 | +16% |
0
%
| 27 Feb ‘26 11 days ago |
|
|
|
Outperform
Maintained
| $81 |
11%
upside
| 2 | -1.8% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Outperform
Initiated
| $75 |
288%
upside
| 1 | -8.9% |
0
%
| 7 Jan ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $18 |
79%
upside
| 1 | +13% |
0
%
| 7 Jan ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $80 |
180%
upside
| 2 | +46% |
0
%
| 23 Sep ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $85 |
39%
downside
| 1 | +154% |
0
%
| 9 Sep ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $35 |
56%
upside
| 1 | +23% |
0
%
| 11 Aug ‘25 7 months ago |
|